Amylin: Physiological roles in the kidney and a hypothesis for its role in hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 9, 1998, Pages 653-660

  Wookey, Peter J ^a   Cooper, Mark E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Amylin; Diabetes; Growth factors; Hypertension; Kidney; Metanephros; Proximal tubules; Sodium homeostasis

Indexed keywords

AMYLIN; GROWTH FACTOR; MESSENGER RNA; SODIUM;

BINDING SITE; BRUSH BORDER; DIABETES MELLITUS; EPITHELIUM CELL; HOMEOSTASIS; HUMAN; HYPERTENSION; KIDNEY; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; NONHUMAN; REVIEW; SECOND MESSENGER; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0031690994     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.tb02272.x     Document Type: Review

References (70)

1. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM. Purification and characterization of a peptide from amyloid rich pancreases of type 2 diabetic patients. Proc. Natl Acad. Sci. USA 1987; 84: 8628-32.
2. Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from neuropeptide - like protein also present in normal islet cells. Proc. Natl Acad. Sci. USA 1987; 84: 3881-5.
3. Johnson KH, O'Brien TD, Hayden DW et al. Immunolocalisation of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein-A gold techniques. Am. J. Pathol. 1988; 130: 1-8.
4. Kahn SE, D'Alessio DA, Schwartz MW et al. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 1990; 39: 634-8.
5. Frontoni S, Choi SB, Banduch D, Rossetti L. In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle. Diabetes 1991; 40: 568-73.
6. Cooper GJ. Amylin compared with calcitonin gene-related peptide: Structure, biology, and relevance to metabolic disease. Endocrine Rev. 1994; 15: 163-201.
7. MacIntyre I. Amylin-amide, bone conservation and pancreatic β-cells. Lancet 1989; ii: 1026-7.
8. Zaidi M, Datta HK, Bevis PJ, Wimalawansa SJ, MacIntyre I. Amylin-amide: A new bone-conserving peptide from the pancreas. Exp. Physiol. 1990; 75: 529-36.
9. Cooper ME, Wookey PJ. Amylin: Its role in the kidney. Nephrol. Dial. Transplant. 1997; 12: 8-10.
10. Wookey PJ, Tikellis C, Du H-C, Qin H-F, Sexton PM, Cooper ME. Amylin binding in rat renal cortex, stimulation of adenylyl cyclase and activation of plasma renin. Am. J. Physiol. 1996; 270: F289-94.
11. Wookey PJ, Tikellis C, Nobes M, Casley D, Cooper ME, Darby IA. Amylin as a growth factor during foetal and postnatal development of the rat kidney. Kidney Int. 1998; 53: 25-30.
12. Wookey PJ, Cao Z, van Geenen RCI et al. Increased density of renal amylin binding sites in experimental hypertension. Hypertension 1997; 30: 455-60.
13. Harris PJ, Cooper ME, Hiranyachattada S et al. Amylin stimulates proximal tubular sodium transport and cell proliferation in the rat kidney. Am. J. Physiol. 1997; 272: F13-21.
14. Williams B. Insulin resistance: The shape of things to come. Lancet 1994; 344: 521-4.
15. Young AA, Rink TJ, Vine W, Gedulin B. Amylin and syndrome-X. Drug Dev. Res. 1994; 32: 90-9.
16. Kolterman OG, Gottlieb A, Moyses C, Colburn W. Reduction of post-prandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue. Diabetes Care 1995; 18: 1179-82.
17. Beaumont K, Kenney MA, Young AA, Rink TJ. High affinity amylin binding sites in rat brain. Mol. Pharmacol. 1993; 44: 493-7.
18. Sexton PM, Paxinos G, Kenney MA, Wookey PJ, Beaumont K. In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience 1994; 62: 553-67.
19. i and stimulates the release of pancreatic digestive enzymes from rat acinar AR42J cells: Evidence for an exclusive receptor system of amylin. Peptides 1996; 17: 497-502.
20. Lin HY, Harris TL, Flannery MR et al. Expression cloning and characterization of a porcine renal calcitonin receptor. Science 1991; 254: 1022-4.
21. Kapas S, Catt K, Clark AJ. Cloning and expression of a cDNA encoding a rat adrenomedullin receptor. J. Biol. Chem. 1995; 270: 25 337-44.
22. Aiyar N, Rand K, Elshourbagy NA et al. A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J. Biol. Chem. 1996; 271: 11 325-9.
23. Kapas S, Clark AJ. Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor. Biochem. Biophys. Res. Commun. 1995; 217: 832-8.
24. Kautzky-Willer A, Thomaseth K, Pacini G et al. Role of islet amyloid polypeptide secretion in insulin-resistant humans. Diabetologia 1994; 37: 188-94.
25. Banks WA, Kastin AJ, Maness LM, Huang WT, Jaspan JB. Permeability of the blood-brain barrier to amylin. Life Sci. 1995; 57: 1993-2001.
26. Chai S, Christopoulos G, Cooper ME, Sexton PM. Localisation and characterisation of renal binding sites for amylin, calcitonin and calcitonin gene-related peptide in primate kidney. Am. J. Physiol. 1998; 274: F51-62.
27. Young AA, Vine W, Carlo P, Rink TJ, Rumble J, Cooper ME. Amylin stimulation of renin activity in rats: A possible link between insulin resistance and hypertension. J. Hypertens. 1994; 12: S152.
28. Young AA, Nuttall A, Moyses C, Percy A, Vine W, Rink TJ. Amylin stimulates the renin-angiotensin-aldosterone axis in rats and man. Diabetologia 1995; 38: A225.
29. Cooper ME, McNally PG, Phillips PA, Johnston CI. Amylin stimulates plasma renin concentration in humans. Hypertension 1995; 26: 460-4.
30. Blakely P, Vaughn DA, Fanestil DD. Amylin, calcitonin gene-related peptide and adrenomedullin: Effects on thiazide receptor and calcium. Am. J. Physiol. 1997; 272: F410-15.
31. Miles PD, Deftos LJ, Moossa AR, Olefsky JM. Islet amyloid polypeptide (amylin) increases the renal excretion of calcium in the conscious dog. Calcif. Tissue Int. 1994; 55: 269-73.
32. Hammerman M. New treatments for acute renal failure: Growth factors and beyond. Curr. Opin. Nephrol. Hypertens. 1997; 6: 7-9.
33. Safirstein R. Gene expression in nephrotoxic and ischaemic acute renal failure. J. Am. Soc. Nephrol. 1994; 4: 1387-95.
34. Toback F. Regeneration after acute tubular necrosis. Kidney Int. 1992; 41: 226-46.
35. Garcia Ocana A, Ortega J, Gonzalez Garcia Y, Garcia Canton C, Esbrit P. Partial purification of a renotropic activity from plasma of uninephrectomized human subjects. Nephron 1993; 64: 547-51.
36. Fine LG, Hammerman MR, Abboud HE. Evolving role of growth factors in the renal response to acute and chronic disease. J. Am. Soc. Nephrol. 1992; 2: 1163-70.
37. Pollock CA, Fields MJ. Compensatory renal hypertrophy: Tubular cell growth and transport studied in primary culture. Nephron 1993; 64: 615-20.
38. Cornish J, Callon KE, Cooper GJ, Reid IR. Amylin stimulates osteoblast proliferation and increases mineralised bone volume in adult mice. Biochem. Biophys. Res. Commun. 1995: 207: 133-9.
39. Datta H, Rafter P, Chen Z, Wimalawansa S, Macintyre I. Amylin-amide displays a proliferative effect on human umbilical vein endothelial cells. Biochem. Soc. Trans. 1990; 18: 1276.
40. Grobstein C. Inductive interaction in the development of the mouse metanephros. J. Exp. Zool. 1955; 130: 319-40.
41. Gossens CL, Unsworth BR. Evidence for a two-step mechanism operating during in vitro mouse kidney tubulogenesis. J. Embryol. Exp. Morphol 1972; 28: 615-31.
42. Sorokin L, Ekblom P. Development of tubular and glomerular cells of the kidney. Kidney Int. 1992; 41: 657-64.
43. Woolf AS, Kolasti-Joannou M, Hardman P et al. Roles of hepatocyte growth factor/scatter factor and the Met receptor in early development of the metanephros. J. Cell Biol. 1995; 128: 171-84.
44. Cantley LG. Growth factors and the kidney: Regulation of epithelial cell movement and morphogenesis. Am. J. Physiol. 1996; 271: F1103-13.
45. Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992; 114: 521-32.
46. Simon M, Grone HJ, Johren O et al. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am. J. Physiol. 1995; 268: F240-50.
47. Kaipainen A, Korhonen J, Pajusola K et al. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J. Exp. Med. 1993; 178: 2077-88.
48. Oelrichs RB, Reid HH, Bernard O, Ziemiecki A, Wilks AF. NYK/FLK-1: A putative receptor protein tyrosine kinase isolated from ElO embryonic neuroepithelium is expressed in endothelial cells of the developing embryo. Oncogene 1993; 8: 11-18.
49. Robert B, St John PL, Hyink DP, Abrahamson DR. Evidence that embryonic kidney cells expressing FLK-1 are intrinsic, vasculogenic angioblasts. Am. J. Physiol. 1996; 40: F744-53.
50. Nadasdy T, Laszik Z, Blick KE et al. Human acute tubular necrosis: A lectin and immunohistochemical study. Hum. Pathol. 1995; 26: 230-9.
51. Ekblom P, Miettinen A, Saxen L. Induction of brush border antigens of the proximal tubule in the developing kidney. Dev. Biol. 1980; 74: 263-74.
52. Hammerman MR. Growth factors in renal development. Semin. Nephrol. 1995; 15: 291-9.
53. Ramirez I, Tebar F, Grau M, Soley M. Role of heterotrimeric G-proteins in epidermal growth factor signalling. Cell Signal. 1995; 7: 303-11.
54. Haynes J, Hodgson W, Cooper ME. Rat amylin mediates a pressor effect in the anaesthetised rat. Diabetologia 1997; 40: 256-61.
55. Bhaysar S, Young AA. The selective amylin antagonist, AC413, prevents sucrose-induced increases in mean arterial pressure in rats. Am. J. Hypertens. 1995; 8: 55A.
56. Cao Z, Wookey PJ, Wu L, Voskuil M, van Geenen RCI, Cooper ME. Renal amylin binding in normotensive and hypertensive rats: Effect of angiotensin converting enzyme inhibition with perindopril. J. Hypertens. 1997; 15: 1245-52.
57. Koch WJ, Rockman HA, Samama Petal. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science 1995; 268: 1350-3.
58. Lean A, Stadel JM, Lefkowitz RJ. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J. Biol. Chem. 1980; 255: 7108-17.
59. Costa T, Ogino Y, Munson PJ, Onaran HO, Rodbard D. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: Thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol. Pharmacol. 1992; 41: 549-60.
60. Gotze K, Jakobs KH. Unoccupied beta-adrenoceptor-induced adenylyl cyclase stimulation in turkey erythrocyte membranes. Eur. J. Pharmacol. 1994; 268: 151-8.
61. Samama P, Cotecchia S, Costa T, Lefkowitz RJ. A mutation-induced activated state of the beta-2 adrenergic receptor: Extending the ternary complex model. J. Biol. Chem. 1993; 268: 4625-36.
62. Lorenzo A, Razzaboni B, Weir GC, Yankner BA. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 1994; 368: 756-60.
63. Lutz TA, Rand JS. Plasma amylin and insulin concentrations in normoglycemic and hyperglycemic cats. Can. Vet. J. 1996; 37: 27-34.
64. Sakagashira S, Sanke T, Hanabusa T et al. Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes 1996; 45: 1279-81.
65. Opie EL. On the relation of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes mellitus. J. Exp. Med. 1901; 5: 397-428.
66. Arendshorst WJ, Beierwaltes WH. Renal and nephron hemodynamics in spontaneously hypertensive rats. Am. J. Physiol. 1979; 236: F246-51.
67. Arendshorst WJ, Beierwaltes WH. Renal tubular reabsorption in spontaneously hypertensive rats. Am. J. Physiol. 1979; 237: F38-4-7.
68. Larson TS, Lockhart JC. Restoration of vasa recta hemodynamics and pressure natriuresis in SHR by L-arginine. Am. J. Physiol. 1995; 268: F907-12.
69. Kato T, Kassab S, Wilkins FC, Kirchner KA, Keiser J, Granger JC. Endothelin antagonists improve renal function in spontaneously hypertensive rats. Hypertension 1995; 25: 883-7.
70. Dohi Y, Kojima M, Sato K. Benidipine improves endothelial function in renal resistance arteries of hypertensive rats. Hypertension 1996; 28: 59-63.